Products

S-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloride, inozivikanwawo seS-(+)-Clopidogrel, inhengo yemishonga ine kemikari formula yeC16H16ClNO2S·HCl. .Inobva kuchiral yeclopidogrel, inova mushonga unokosha weantiplatelet.Kushandiswa kwekutanga kweS-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloride is as an active chidimbu mukugadzirwa kwemishonga yemwoyo, kunyanya antiplatelet agents.Inoshandisa maitiro ayo ekurapa nekudzivisa platelet aggregation, kudzivirira kuumbwa kweropa, uye kuderedza njodzi yezviitiko zvemoyo.Chikamu chacho chinosarudza chinangwa cheP2Y12 receptor pamaplatelet, iyo inotamba Nekusunga zvisingachinjike kune iyi receptor, S-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloride inhibits platelet activation uye kudzivirira kuumbwa. Kugwamba kweropa.Iyi nzira yekuita inoita kuti uve mushonga wakakosha kudzivirira zviitiko zvethrombotic muvarwere vari panjodzi huru, sevaya vane nhoroondo yeacute coronary syndrome, ischemic stroke, kana peripheral artery disease.S-(+) -Methyl- (2-chlorophenyl) [(2-(2-thienyl) amino] acetate hydrochloride inowanzoitwa nemuromo nenzira yemapiritsi kana capsules.Mushure mekudya, inoshandura metabolic muchiropa kuti ibudise iyo inoshanda metabolite.Iyi metabolite inoshanda inosunga zvisingachinjike kuP2Y12 receptor, ichishandisa antiplatelet yayo mhedzisiro kwenguva yakareba.Mushonga wacho unowanzo kurongerwa kamwe chete pazuva, kungave sekurapa kwakazvimirira kana kusanganiswa nemimwe mishonga yeantiplatelet, yakadai seaspirin. Zvakakosha kuziva kuti S-(+) -Methyl-(2-chlorophenyl)[(2-(2) -thienyl)amino] acetate hydrochloride inofanira kungoshandiswa pasi pekutungamirirwa kwenyanzvi yehutano, sezvo kushandiswa kwayo kunogona